Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Esperion Therapeutics Inc NE

CUSIP: 29664W955 | 11 institutional holders

Quarters

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile